SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-22-048878
Filing Date
2022-09-06
Accepted
2022-09-06 19:21:58
Documents
2
Period of Report
2022-05-18

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3982
2 POA DOCUMENT poa.txt EX-24 3051
  Complete submission text file 0001209191-22-048878.txt   8427
Mailing Address 4225 EXECUTIVE SQUARE SUITE 600 SAN DIEGO CA 92037
Business Address 4225 EXECUTIVE SQUARE SUITE 600 SAN DIEGO CA 92037 858-369-7800
Metacrine, Inc. (Issuer) CIK: 0001634379 (see all company filings)

IRS No.: 472297384 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O METACRINE, INC. 3985 SORRENTO VALLEY BLVD., SUITE C SAN DIEGO CA 92121
Business Address
Evans Ronald M (Reporting) CIK: 0001823355 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39512 | Film No.: 221229557